Regulation of CMV promoter-driven exogenous gene expression with doxorubicin in genetically modified cells

Journal of Pharmacy and Pharmacology

Volumn 60, Issue 12, 2008, Pages 1659-1665

  Kinoshita, Atsushi ^a   Kobayashi, Daisuke ^b   Hibino, Yasuhide ^b   Isago, Tomokazu ^b   Uchino, Katsuyoshi ^c   Yagi, Keiko ^d   Hirai, Midori ^e   Saitoh, Yukiya ^b   Komada, Fusao ^a  

^a HIMEJI DOKKYO UNIVERSITY   (Japan)

^b JOSAI UNIVERSITY   (Japan)

^c TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^d KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^e KOBE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DOXORUBICIN; ENHANCED GREEN FLUORESCENT PROTEIN; MESSENGER RNA; METHOTREXATE; PLASMID VECTOR; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; CYTOMEGALOVIRUS; EXPRESSION VECTOR; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NONHUMAN; ONCOGENE C FOS; ONCOGENE C JUN; PROMOTER REGION; RAT; SKIN FIBROBLAST;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; CELL LINE; CELL LINE, TUMOR; CYTOMEGALOVIRUS; DNA, COMPLEMENTARY; DOXORUBICIN; FIBROBLASTS; GENE EXPRESSION REGULATION; GENE THERAPY; GREEN FLUORESCENT PROTEINS; HUMANS; METHOTREXATE; PROMOTER REGIONS, GENETIC; RATS; RNA, MESSENGER; TIME FACTORS; TRANSFECTION;

EID: 56849127693     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.60.12.0012     Document Type: Article

References (24)

1. Billingham, M. E., Mason, J. W., Bristow, M. R., Daniels, J. R. (1978) Anthracycline cardiomyopathy monitored by morphologic changes. Cancer Treat. Rep. 62: 865-872
2. Cronstein, N. B., Eberle, A. M., Gruger, E. H., Levin, I. R. (1991) Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc. Natl Acad. Sci. USA 88: 2441-2445
3. Doroshow, J. H., Davies, K. J. A. (1986) Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide, and hydroxyl radical. J. Biol. Chem. 261: 3068-3074
4. Dorr, R. T. (1996) Cytoprotective agents for anthracyclines. Semin. Oncol. 23: 23-34
5. Hai, T., Curran, T. (1991) Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl Acad. Sci. USA 88: 3720-3724
6. Harvey, D. M., Caskey, C. T. (1998) Inducible control of gene expression: prospects for gene therapy. Curr. Opin. Chem. Biol. 2: 512-518
7. Hollander, M. C., Fornace, A. J. J. (1989) Induction of fos RNA by DNA-damaging agents. Cancer Res. 49: 1687-1692
8. Ito, H., Shimojo, T., Fujisaki, H., Tamamori, M., Ishiyama, S., Adachi, S., Abe, S., Marumo, F., Hiroe, M. (1999) Thermal preconditioning protects rat cardiac muscle cells from doxorubicin-induced apoptosis. Life Sci. 64: 755-761
9. Kim, M. H., Cho, H. S., Jung, M., Hong, M. H., Lee, S. K., Shin, B. A., Ahn, B. W., Jung, Y. D. (2005) Extracellular signal-regulated kinase and AP-1 pathways are involved in reactive oxygen species-induced urokinase plasminogen activator receptor expression in human gastric cancer cells. Int. J. Oncol. 26: 1669-1674
10. Kim, I. K., Kang, H. J., Chung, J.-K., Lee, J. Y., Jeong, M. J., Lee, S. D., Lee, C. M. (2007) Doxorubicin enhances the expression of transgene under control of the CMV promoter in anaplastic thyroid carcinoma cells. J. Nucl. Med. 48: 1553-1561
11. Kinoshita, A., Kobayashi, D., Saitoh, Y., Tanabe, N., Uchino, K., Nishiguchi, K., Okumura, K., Komada, F. (2006) Regulation of exogenous gene expression by superoxide. Pharm. Res. 23: 2536-2541
12. Kitami, A., Suzuki, T., Kamio, Y., Suzuki, S. (2001) Chemotherapy of thymic carcinoma: analysis of seven cases and review of the literature. Jpn J. Clin. Oncol. 31: 601-604
13. Komada, F., Nishiguchi, K., Tanigawara, Y., Iwakawa, S., Okumura, K. (1999) Effects of secretable SOD delivered by genetically modified cells on xanthine/xanthine oxidase and paraquat-induced cytotoxicity in vitro. Biol. Pharm. Bull. 22: 846-853
14. Lee, W., Mitchell, P., Tjian, R. (1987) Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49: 741-752
15. Li, X., Sun, A. Y. (1996) Paraquat induced activation of transcription factor AP-1 and apoptosis in PC12 cells. J. Neural. Transm. 106: 1-21
16. Li, X., Chen, D., Yin, S., Meng, Y., Yang, H., Landis-Piwowar, K. R., Li, Y., Sarkar, F. H., Reddy, G. P., Dou, Q. P., Sheng, S. (2007) Maspin augments proteosome inhibitor-induced apoptosis in prostate cancer cells. J. Cell Physiol. 212: 298-306
17. Mross, K., Maessen, P., Van Der Vijgh, W. J., Gall, H., Boven, E., Pinedo, H. M. (1988) Pharmacokinetics and metabolism of epidoxorubicin and doxorubicin in humans. J. Clin. Oncol. 6: 517-526
18. Ogura, M. (2001) Adriamycin (doxorubicin). Gan To Kagaku Ryoho 28: 1331-1338
19. Okumura, K., Nishiguchi, K., Tanigawara, Y., Mori, S., Iwakawa, S., Komada, F. (1997) Enhanced anti-inflammatory effects of Cu, Zn-superoxide dismutase delivered by genetically modified skin fibroblasts in vitro and in vivo. Pharm. Res. 14: 1223-1227
20. Springer, J., Pleimes, D., Scholz, F. R., Fischer, A. (2005) Substance P mediates AP-1 induction in A549 cells via reactive oxygen species. Regul. Pept. 124: 99-103
21. Svensson, U. R., Barnes, M. J., Rokhlin, W. O., Cohen, B. M., Henry, D. M. (2007) Chemotherapeutic agents up-regulated the cytomegalovirus promoter: implications of bioluminescence imaging of tumor response to therapy. Cancer Res. 67: 10445-10454
22. Usui, T., Saitoh, Y., Komada, F. (2003) Induction of CYP3As in HepG2 cells by several drugs. Association between induction of CYP3A4 and expression of glucocorticoid receptor. Biol. Pharm. Bull. 26: 510-517
23. Zhang, J., Clark, J. R. Jr., Herman, E. H., Ferrans, V. J. (1996) Doxorubicin-induced apoptosis in spontaneously hypertensive rats: differential effects in heart, kidney and intestine, and inhibition by ICRF-187. J. Mol. Cell Cardiol. 28: 1931-1943
24. Zhou, L. Z., Johnson, A. P., Rando, T. A. (2001) NF kappa B and AP-1 mediate transcriptional responses to oxidative stress in skeletal muscle cells. Free Radic. Biol. Med. 31: 1405-1416